313337-32-5 Usage
Uses
Used in Pharmaceutical Industry:
1H-Indole,4-fluoro-7-methyl-(9CI) is used as an intermediate in the synthesis of various pharmaceuticals for its ability to contribute to the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, 1H-Indole,4-fluoro-7-methyl-(9CI) is utilized as a precursor in the production of agrochemicals, aiding in the creation of compounds that can enhance crop protection and yield.
Used in Organic Synthesis:
1H-Indole,4-fluoro-7-methyl-(9CI) serves as a valuable building block in organic synthesis, enabling the production of a wide range of chemical products across various industries, from specialty chemicals to advanced materials.
Check Digit Verification of cas no
The CAS Registry Mumber 313337-32-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,1,3,3,3 and 7 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 313337-32:
(8*3)+(7*1)+(6*3)+(5*3)+(4*3)+(3*7)+(2*3)+(1*2)=105
105 % 10 = 5
So 313337-32-5 is a valid CAS Registry Number.
313337-32-5Relevant academic research and scientific papers
DISUBSTITUTED [4-(5-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-1H-INDOL-3-YL]-METHANONES
-
Page/Page column 43, (2011/04/13)
The present invention extends to the compound of formula I: or a prodrug, pharmaceutically acceptable salt, or solvate of said compound. Furthermore, the present invention is directed to a pharmaceutical composition comprising a pharmaceutically effective
Antiviral indoleoxoacetyl piperazine derivatives
-
, (2008/06/13)
This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the invention is concerned with indoleoxoacetyl piperazine derivatives. These compounds possess unique antiviral activity, whether used alone or in combination with other antivirals, antiinfectives, immunomodulators or HIV entry inhibitors. More particularly, the present invention relates to the treatment of HIV and AIDS.
